Home/ConvaTec/John C. (Chris) Mills
JC

John C. (Chris) Mills

Chief Financial Officer

ConvaTec

ConvaTec Pipeline

DrugIndicationPhase
Hydrofiber® EVOLUTIONAdvanced Wound CareCommercial
ConvaTec Innovation Initiative (CII)Ostomy Care (Smart Devices)R&D
me+™ Program ExpansionPatient Support ServicesRoll-out
Neria™ Guard Infusion SetsSubcutaneous Drug DeliveryMarket Expansion
Advanced Skin Barrier TechnologiesOstomy & Continence CareR&D